Two dividend stocks to watch in 2025

Investing in dividend stocks is great for many reasons, with one of the biggest benefits being that companies that can pay growing dividends over the long term usually have a strong and stable underlying business.

It's even better to invest in excellent dividend stocks when their prices seem attractive, which isn't always easy to find because these companies are highly valued.

AbbVie $ABBV: Stability despite challenges

Recent years have been turbulent for AbbVie. The company lost patent exclusivity on its best-selling drug Humira in early 2023, which led to a significant drop in revenue, earnings, and stock price. Despite this, the company managed to recover from the blow, but its stock suffered further losses late last year when one of its promising products, emraclidine (a potential treatment for schizophrenia), failed in Phase 2 clinical trials.

While AbbVie was able to recoup most of the losses from that failed phase, its stock is still fairly valued, at least according to one of the…

Read the full article for free?
Go ahead 👇

Do you have an account? Then log in . Or create a new one .

No comments yet
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Posts StockBot Tracker